Hospitalization rates for Covid dropped steadily in USA over past month, Deaths have been flat
US hospitalization rates for Covid are now half what they were during the second peak in July.

UPDATE June 23: WHO removed it pediatric Covid vaccine guidance a day after posting it. Heads must be rolling in Geneva. Then ACIP had a god-awful meeting the next day, not only minimizing the troublisng issue of myocarditis, but putting out a call for boosters in the very near future, even without data! Below is…
Rob Stein at the Post discusses a “hint” that swine flu vaccine may have caused increased cases of Guillain Barre Syndrome, Bell’s Pallsy and thrombocytopenia. The US CDC, unlike its counterpart in Australia, manages the news on vaccine adverse events closely, especially for swine flu. Remember that CDC hosted a meeting for invited journalists and…
1. Are Americans who receive vaccines under EUA experimental subjects? · Definitely yes. An EUA product is not a law unto itself. According to 21CFR Subchapter D Part 312: “an experiment is any use of a drug except for the use of a marketed drug in the course of medical practice.” · FDA Commissioner Stephen Hahn told USA Today. · Medicines and vaccines…
Article by Patrick White: A “perplexing” Canadian study linking H1N1 to seasonal flu shots is throwing national influenza plans into disarray and testing public faith in the government agencies responsible for protecting the nation’s health. Distributed for peer review last week, the study confounded infectious-disease experts in suggesting that people vaccinated against seasonal flu are…
The scoop on bullet wounds is very simple: fired from a long distance, the bullet enters an object making a small entry wound, usually the size of the bullet, and leaves the object with an exit wound the same size or, usually, larger. From the medical website “Explore Forensics“: Exit wounds – as we have…
US DHHS Orders for Bulk Supply of 2009 H1N1 Influenza Vaccine Antigens and Squalene-containing Adjuvants Manufacturer Bulk Vaccine Antigen Oil-In-Water Bulk Adjuvant Novartis $150 million $139 million GlaxoSmithKline $ 38 million $144 million Sanofi Pasteur $191 million CSL Biotherapies $180 million MedImmune $ 90 million Total $649 million $283 million